Safety Study of Viaskin Peanut to Treat Peanut Allergy

PHASE3CompletedINTERVENTIONAL
Enrollment

393

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 22, 2017

Study Completion Date

October 7, 2020

Conditions
Peanut Allergy
Interventions
BIOLOGICAL

Viaskin Peanut 250 mcg

BIOLOGICAL

Placebo

Trial Locations (32)

10029

Mount Sinai Medical Center, New York

15213

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

21205

Johns Hopkins Hospital, Baltimore

27599

The University of North Carolina - Chapell Hill, Chapel Hill

29407

National Allergy and Asthma Research, Charleston

30060

Atlanta Allergy & Asthma Clinic, Marietta

34239

Sarasota Clinical Research, Sarasota

55441

Clinical Research Institute, Plymouth

60611

Ann & Robert H. Lurie Children's Hospital of CHicago, Chicago

62704

Sneeze, Wheeze and Itch Associates,Clinical Research, Normal

64108

Children's Mercy Hospital, Kansas City

68123

The Asthma and Allergy Center, Bellevue

72202

Arkansas Children's Hospital, Little Rock

77030

Baylor College of Medicine - Texas Children's Hospital, Houston

78229

Sylvana Research, San Antonio

78251

STAAMP Research, San Antonio

80045

Children's Hospital Colorado, Aurora

80206

National Jewish Health, Denver

90274

Palos Verdes Medical Group, Rolling Hills Estates

92691

Allergy & Asthma Associates of Southern California, Mission Viejo

94304

Stanford University School of Medicine, Stanford

02114

Massachusetts General Hospital, Boston

02115

Boston Childrens' Hospital, Boston

75390-9105

Children's Medical Center of Dallas, Dallas

98115-2060

ASTHMA, Inc. Clinical Research, Seattle

V6H 3N1

Children's and Women's Health Centre of Brisith Columbia, Vancouver

L5A 3V4

Alpha Medical Research Inc., Mississauga

K1G 6C6

Ottawa Allergy Asthma Research Institute, Ottawa

M4V 1R2

Gordon Sussman Clinical Research Inc., Toronto

H3T 1C5

Centre Hospitalier Universitaire Sainte Justine, Montreal

G1V 4W2

Centre De Recherche Applique, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DBV Technologies

INDUSTRY

NCT02916446 - Safety Study of Viaskin Peanut to Treat Peanut Allergy | Biotech Hunter | Biotech Hunter